سعر ميناكترا 0.5مل فيال محلول للحقن عضل 2022

Quadrivalent meningococcal (A, C, Y, W-135) polysaccharide diphtheria toxoid conjugate vaccine, 0.5 mL single-dose vial for intramuscular injection.

• Active immunization to prevent invasive meningococcal disease caused by N. meningitidis serogroups A, C, Y and W-135 (does not prevent serogroup B disease).Population: Individuals 9 months through 55 yearsDailyMed (U.S. National Library of Medicine)

• Most common solicited reactions in adolescents and adults after a single dose: injection-site pain, headache and fatigue; in young children, injection-site tenderness and irritability are commonly reported.International label, same product · DailyMed (U.S. National Library of Medicine)

• Severe allergic reaction (e.g. anaphylaxis) after a previous dose of a meningococcal capsular polysaccharide-, diphtheria toxoid- or CRM197-containing vaccine, or to any component of Menactra.International label, same product · DailyMed (U.S. National Library of Medicine)

• Persons previously diagnosed with Guillain-Barre syndrome may be at increased risk of GBS after Menactra; weigh benefits and risks.International label, same product · DailyMed (U.S. National Library of Medicine)
• Epinephrine and other agents for immediate allergic reactions must be immediately available; review immunization history before vaccination.International label, same product · DailyMed (U.S. National Library of Medicine)
• Individuals with altered immunocompetence, including those on immunosuppressants, may have reduced immune responses. Persons with certain complement deficiencies or receiving terminal complement inhibitors (e.g. eculizumab) remain at increased risk of invasive meningococcal disease even after vaccination.International label, same product · DailyMed (U.S. National Library of Medicine)

• DAPTACEL (DTaP vaccine)In children 4-6 years, give Menactra simultaneously with or before DAPTACEL; giving Menactra one month after DAPTACEL reduced meningococcal antibody responses.DailyMed (U.S. National Library of Medicine)
• Pneumococcal 7-valent conjugate vaccine (PCV7)Pneumococcal antibody responses to some PCV7 serotypes were decreased after co-administration with Menactra.DailyMed (U.S. National Library of Medicine)
• Immunosuppressive therapies (irradiation, antimetabolites, alkylating agents, cytotoxic drugs, high-dose corticosteroids)May reduce the immune response to the vaccine.DailyMed (U.S. National Library of Medicine)

• No adequate and well-controlled US studies in pregnant women; available data suggest rates of major birth defects and miscarriage after Menactra within 30 days before or during pregnancy are consistent with background rates. A pregnancy exposure registry exists (Sanofi).International label, same product · DailyMed (U.S. National Library of Medicine)
• Data are not available on effects on the breastfed infant or on milk production/excretion; weigh breastfeeding benefits against the mother's need for vaccination.International label, same product · DailyMed (U.S. National Library of Medicine)

English text not available for this section.